BMC Anesthesiology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2018-03-16 无宇伦比

这个要版面费么

295 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2019-12-12 月朗_星稀

一审几个月？医网情深 2019-08-02 00:00:00 发表:
小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！

医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！

151 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2022-12-01 ms2000001433478038 来自福建省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学
经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2021-07-14 gouniu

投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2018-05-30 wenjian1998

危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。

337 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2019-08-02 医网情深

我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！

227 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2024-05-13 147dadaam95暂无昵称来自福建省

审稿周期长，半年多才一审回来。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2024-03-12 inchina888999 来自浙江省

投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多

25 0

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2024-01-13 123d52b7m36暂无昵称来自山东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！

30 0

[GetPortalCommentsPageByObjectIdResponse(id=553750, encodeId=cb16553e5089, content=这个要版面费么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aae1637999, createdName=无宇伦比, createdTime=Fri Mar 16 00:00:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581356, encodeId=b2bd58135606, content=一审几个月？医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, beContent=医网情深 2019-08-02 00:00:00 发表: 小修后修回已经3个月了，一直处于editor assessment，催稿2次了！还有机会接受吗？急啊！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/83d9e966449540c7ba1b5f1d2dc814ef/4ff44515ee3046f78935a8ce47d0b02a.jpg, createdBy=0ae02553831, createdName=月朗_星稀, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103689, encodeId=a2d7210368925, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床麻醉;围术期器官功能保护;重症医学 经验分享：2022年4月24投稿，10月10号一审返修，11月18直接接受，中间催了一次稿，主要原因是我的研究小众，找不到第二个审稿人。总的来说还算顺利，历经2年，有一篇论文发表在bmc anesthesiology.中国作者文章占31%，希望该期刊努力进入中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a205682991, createdName=ms2000001433478038, createdTime=Thu Dec 01 11:24:24 CST 2022, time=2022-12-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999271, encodeId=b7729992e199, content=投稿过程发现一个问题，官网链接（）和投稿链接（editorial manager）是两个不同的投稿系统，而且官网链接这个投稿系统是没有approval的？大神们请指教一下，用哪个投稿系统啊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d19104762, createdName=gouniu, createdTime=Wed Jul 14 00:24:24 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557404, encodeId=518b55e4047f, content=危重病方向，从投稿到介绍4个月左右。2018-1-23投稿， 2-13交处理编辑，4-1一审完成大修，25天左右修回，5-1进入修改稿流程，5-23小修，1天后修回，5-25助理编辑通知改部分格式细节，当天修回，5-30 Accept。总体感觉除了一审前编辑部流程比较长外，后续流程还是比较顺利，编辑、审稿人都非常nice，给了很多中肯的意见，收获很多。The first one,mark一下，期待以后顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Wed May 30 19:43:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574339, encodeId=c5295e43397e, content=我小修修回已经3个月了，催稿2次，目前一直处于Editor assessment阶段，请问还会接受吗？捉急啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70d2282573, createdName=医网情深, createdTime=Fri Aug 02 21:29:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181089, encodeId=57ca2181089c1, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：审稿特别慢，我的一篇文章被审了4个月，中间还替换了审稿人，不建议投，浪费时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7f02440957, createdName=123d52b7m36暂无昵称, createdTime=Sat Jan 13 02:01:27 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210187, encodeId=9b46121018e58, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。 从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。 二审极慢，等了2个月，差点就写催稿信。 WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。 二修后3天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55135581960, createdName=风过梦恒, createdTime=Mon Apr 11 08:17:06 CST 2022, time=2022-04-11, status=1, ipAttribution=)]

2022-04-11 风过梦恒

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：临床研究
经验分享：投个基础研究，整体期刊基础研究做的少，偏向于临床。
从投到接收4个多月。12月投稿，4月初接收。一审很快，约2周，2名reviewer提问。
二审极慢，等了2个月，差点就写催稿信。
WB、流式要三重复的raw materials，看运气其中一个reviewer友好，一个reviewer事多。
二修后3天接收。

52 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务